
Introduction: Revision septorhinoplasty is a technically demanding surgery addressing persistent functional obstruction, aesthetic deformity, or both in patients with prior rhinoplasty. Objectives & Hypotheses: This narrative review aims to synthesize evidence on assessment, patient selection, and postoperative care, and provide evidence-based operative strategies for common revision deformities. Study Design: Narrative review. Methods: A structured review of PubMed/MEDLINE, Embase, and Scopus was undertaken, supplemented by guidelines and reference-list screening. Search terms included revision/secondary septorhinoplasty, psychological assessment, postoperative care, and emerging technologies. The review incorporated original studies, systematic reviews, meta-analyses, clinical guidelines, and technical reports, prioritizing recent evidence directly relevant to revision septorhinoplasty. Results: Successful management requires patient selection, psychological screening, expectation management, and evaluation of function and structural deformity. Evidence-based operative strategies are presented for pollybeak deformity, saddle nose, residual bony deviation, dorsal irregularities, columellar deformity, residual dorsal hump, and minor asymmetry. Stable structural reconstruction should precede contour refinement, with techniques individualized to the underlying mechanism and tissue deficit. Conclusions: Revision septorhinoplasty requires an individualized approach integrating patient selection, psychological assessment, deformity analysis, functional reconstruction, and aesthetic refinement. Evidence-based, deformity-specific operative planning provides a framework for decision-making; however, higher-quality revision-specific studies and standardized outcome reporting are needed to strengthen future practice.
Aims and Backgrounds Healthcare is a major global carbon emitter, driven by surgical waste, pharmaceutical inefficiencies, and long patient travel. Facial paralysis management requires complex, multidisciplinary care where delays degrade outcomes. This review synthesizes literature on sustainability and accessibility across the facial paralysis care continuum to formulate evidence-based clinical recommendations. Patient Selection Following PRISMA-ScR guidelines, PubMed, Embase, Cochrane CENTRAL, and Scopus were searched through June 2026 using PICOS criteria to evaluate telemedicine, multidisciplinary care, ambulatory surgery, low-resource surgical alternatives, and vial protocols. Techniques Virtual visits reduced follow-up times by ~50% and costs up to 79.8% while maintaining high satisfaction. Multidisciplinary clinic models consolidated care, reducing provider visits (4.8 vs. 6.8; P < .01) and charges by 50%. Ambulatory surgical centers (ASCs) lowered costs by 26% and reduced readmissions relative to inpatient settings. Temporalis tendon transfer (TTT) and selective neurolysis offer single-stage, low-resource outpatient alternatives to complex microvascular procedures. Multi-patient botulinum toxin vial-sharing protocols successfully mitigated pharmaceutical waste with negligible complication rates. Conclusions and Clinical Relevance Transitioning toward digital health, multidisciplinary pathways, ambulatory routing, and optimized pharmaceutical protocols enhances sustainability and geographic access while preserving high-quality clinical outcomes.
Aims and Backgrounds Artificial intelligence (AI) is increasingly relevant to facial plastic surgery. This narrative review examines applications in education, research, and clinical workflows, including tools embedded in the electronic health record (EHR), and discusses responsible adoption. Technology Applications include educational content generation, surgical skill assessment, facial measurement, research assistance, preoperative simulation and planning, decision support, chart summarization, ambient documentation, and patient-message drafting. Agentic workflows could coordinate clinical tasks. Current and Future Development Available evidence primarily evaluates feasibility, content quality, measurement agreement, and workflow effects rather than improved clinical outcomes. Hallucinations, readability, privacy, safety, and bias require attention. Priorities include external validation, outcome assessment, and governance with continued monitoring as systems change. Conclusions and Clinical Relevance AI should augment surgeons, with oversight proportionate to clinical risk, protection of patient information, and assessment across patient groups. Its value should be judged by demonstrated improvements in clinical work, patient experience, and meaningful outcomes.
Introduction The surgical treatment strategies of facial paralysis are diversified, and the existing research lacks systematic integration of global research trends and core hotspots. Objectives and Hypotheses The purpose of this study is to sort out the research status, hotspots, and development trends of surgical treatment of facial paralysis worldwide from 2015 to 2025 through bibliometric analysis, so as to provide reference for future research. Study Design This is a bibliometric analysis. Methods Literatures related to the surgical treatment of facial paralysis were retrieved from the Web of Science Core Collection, and bibliometric analysis was performed using CiteSpace software. Results A total of 240 publications were included. The annual publication output showed a steady increase. China, the United States, and Italy were the leading contributing countries. The most prolific institutions included Harvard Medical School, the University of Milan, and the University of Toronto. Keywords and cluster analysis showed that the research hotspots focused on facial nerve decompression, nerve transfer, functional free muscle transplantation, selective neurotomy, and facial dynamic reconstruction. Emerging trends include dual innervation techniques, neurovascular free flaps, and the integration of electromyographic feedback and artificial intelligence in surgical planning. Conclusion The surgical treatment of facial paralysis is an area of continuous dynamic development, with increasing emphasis on functional recovery and individualized treatment strategies. Strengthening international cooperation and multidisciplinary integration is crucial for future progress. The results of this study can serve as a reference for future research directions and clinical practice.
Abstract Hyaluronidase “melts” hyaluronic acid (HA); no such antidote exists for calcium hydroxylapatite (CaHA). Experimental evidence demonstrating efficacy of hyaluronidase in treating arterial compromise due to CaHA is lacking. Nevertheless, its use is mentioned in papers describing the management of vascular occlusion due to CaHA. The objective of this study is to investigate the efficacy of hyaluronidase as a treatment for CaHA-induced arterial occlusion using the leporine auricular artery as a model. This is a prospective case–control series. Six Oryctolagi cuniculi were divided into two groups of three, Groups 1 and 2. Right auricular blood flow was examined by Doppler in all six. In all six, the right auricular artery was then occluded by injection of CaHA. Occlusion was confirmed by Doppler. On Day 0, Group 1 received injection of hyaluronidase, Group 2 did not. In each group, one occluded ear was biopsied on Day 1 and another on Day 4. On Day 7, the third occluded ear in each group was examined by Doppler and then biopsied. Doppler demonstrated that without hyaluronidase blood flow rate at Day 7 was only 10% of the pre-occlusion flow rate, whereas with hyaluronidase blood flow rate at Day 7 was considerably recovered at 58% of the pre-occlusion rate. Histology revealed a similar story: without hyaluronidase at Day 7 the arterial wall anatomy was largely destroyed, whereas with hyaluronidase the arterial wall anatomy was largely conserved. Hyaluronidase improves tissue viability after arterial occlusion by CaHA. This finding has important implications for patient care.